Medtech Insight is part of Pharma Intelligence UK Limited

This site is operated by Pharma Intelligence UK Limited, a company registered in England and Wales with company number 13787459 whose registered office is 5 Howick Place, London SW1P 1WG. The Pharma Intelligence group is owned by Caerus Topco S.à r.l. and all copyright resides with the group.

This copy is for your personal, non-commercial use. For high-quality copies or electronic reprints for distribution to colleagues or customers, please call +44 (0) 20 3377 3183

Printed By


AdvaMed Making Push For Device Tax Repeal In Lame Duck Session

Executive Summary

The "lame duck" session of Congress before newly elected members take their seats in January may be the best shot available for the device industry to win permanent device tax repeal, lobby group AdvaMed says. The group is making a major effort to repeal the tax before the new Congress takes over.

You may also be interested in...

'Lame Duck' Bill Would Halt Device Tax Until 2025

A revised tax bill introduced by the top lawmaker in the Ways and Means Committee could freeze the Obamacare medical device tax for an additional five years. It is expected a new Congress will be more politically contentious, making it harder to pass an extended moratorium or repeal the bill; this latest effort may be industry’s best chance.

Device Sector Braces For Investigative Stories Critical Of Industry

AdvaMed has gotten wind over the past year that a major global investigative news consortium is planning to roll out a series of articles and broadcasts that are likely to be highly critical of the medical device industry. The group says it has been engaging with reporters in a push for balance.

Massive Family Dollar Rat Infestation Leads To Multi-State Recall

The US FDA found more than 2,000 rats at an Arkansas Family Dollar distribution center, leadingto a six-state recall for products including feminine hygiene products, contact lens cleaners and face masks.


Latest Headlines
See All



Ask The Analyst

Ask the Analyst is free for subscribers.  Submit your question and one of our analysts will be in touch.

Your question has been successfully sent to the email address below and we will get back as soon as possible. my@email.address.

All fields are required.

Please make sure all fields are completed.

Please make sure you have filled out all fields

Please make sure you have filled out all fields

Please enter a valid e-mail address

Please enter a valid Phone Number

Ask your question to our analysts